A switch to PI-based ART may reverse or mitigate INSTI-related weight gain in patients with HIV, with a trend toward weight loss more evidence over time.

High rates of virologic suppression were observed among Black patients who received long-term ART with BIC/FTC/TAF for HIV management.

Astellas Pharma Ltd. today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted authorization for PADCEV™ (enfortumab vedotin, an antibody-drug conjugate [ADC]) in ...

Improving HIV Treatment in Children and Adolescents -- The Right Way July 18, 2024 — Globally, around 2.6 million children and adolescents are currently living with HIV, the majority of them in ...

The Indian Patent Office has rejected Viiv Healthcare's patent application for the HIV drug, dolutegravir, after nearly a ...

To bridge the gap until generic versions become available, Gilead has also committed to supply the product at no profit to ...

The start of AIDS Awareness Month puts a spotlight on how treatment for HIV and AIDS has progressed over the past 40 years. Treatment for HIV/AIDS has consistently seen progress each decade ...

The HIV Integrase pipeline drugs market research report outlays comprehensive information on the HIV Integrase targeted therapeutics, complete with analysis by indications, stage of development, ...

This observational retrospective study examined a cohort of patients diagnosed with HIV from January 2016 to December 2022. Data were sourced from the China Information System for Disease Control and ...

A year ago, life for many people in the UK with attention deficit hyperactivity disorder (ADHD) became unpredictable and disorientating as their medications suddenly became scarce. They were told ...

The Central Drug Standards Control Organisation (CDSCO) has flagged more than 50 drugs for common conditions like high blood pressure and acid reflux as substandard. This includes batches from ...